Mountain View, CA, United States of America

Bn Immunotherapeutics, Inc.


USPTO Granted Patents = 8

% Expired Patents = 75.0

Forward Citations = 65

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Alain Delcayre (4 out of 14 patents)

silverMedal Stefanie Mandl (4 out of 4 patents)

bronzeMedal Reiner Laus (4 out of 4 patents)

4.  Klaus Gregorius Nielsen (4 out of 9 patents)

5.  Ryan Blair Rountree (2 out of 2 patents)

6.  Fatema Legrand (2 out of 2 patents)

7.  Marie Eskling (2 out of 2 patents)

8.  Lucilla Steinaa (2 out of 6 patents)

9.  Jesper Haaning (2 out of 2 patents)

10.  Iben Dalum (2 out of 4 patents)

11.  Dana Leach (2 out of 3 patents)

12.  Gunilla Karlsson (2 out of 3 patents)

13.  Anand Gautam (2 out of 3 patents)

14.  Søren Mouritsen (2 out of 5 patents)

15.  Peter Birk Rasmussen (1 out of 10 patents)


8 patents:

BN Immunotherapeutics, Inc. is a biopharmaceutical company focused on developing innovative immunotherapies for the treatment of cancer. The company's cutting-edge research and development efforts are aimed at harnessing the power of the immune system to target and destroy cancer cells. With a commitment to advancing the field of immuno-oncology, BN Immunotherapeutics is dedicated to improving outcomes for cancer patients worldwide.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#293 in Mountain View, CA

#8,531 in California

#35,893 in US

Mountain View, CA (US)
Mountain View, CA, United States of America
Forward Citations = 65

16 inventors:

Please report any incorrect information to [email protected]
Loading…